Table of Contents Author Guidelines Submit a Manuscript
Pain Research and Treatment
Volume 2012 (2012), Article ID 154781, 8 pages
http://dx.doi.org/10.1155/2012/154781
Review Article

Antineuropathic and Antinociceptive Drugs Combination in Patients with Chronic Low Back Pain: A Systematic Review

1Centro di Chirurgia Ricostruttiva, Istituto Ortopedico I.R.C.C.S. Galeazzi, Via R. Galeazzi 4, 20161 Milano, Italy
2Centro di Medicina del Dolore, Casa di cura S. Pio X, Fondazione Opera San Camillo, Via F. Nava 31, 20159 Milano, Italy

Received 8 January 2012; Revised 4 February 2012; Accepted 8 February 2012

Academic Editor: Young-Chang P. Arai

Copyright © 2012 Carlo Luca Romanò et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. J. Woolf, G. J. Bennett, M. Doherty et al., “Towards a mechanism-based classification of pain?” Pain, vol. 77, no. 3, pp. 227–229, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Cruccu, “Treatment of painful neuropathy,” Current Opinion in Neurology, vol. 20, no. 5, pp. 531–535, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Forde, “Adjuvant analgesics for the treatment of neuropathic pain: evaluating efficacy and safety profiles,” Journal of Family Practice, pp. 3–12, 2007. View at Google Scholar · View at Scopus
  4. C. J. Woolf, “Pain: moving from symptom control toward mechanism-specific pharmacologic management,” Annals of Internal Medicine, vol. 140, no. 6, pp. 441–451, 2004. View at Google Scholar · View at Scopus
  5. D. C. Cherkin, K. J. Wheeler, W. Barlow, and R. A. Deyo, “Medication use for low back pain in primary care,” Spine, vol. 23, no. 5, pp. 607–614, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Gilron, E. Orr, D. Tu, J. Peter O'Neill, J. E. Zamora, and A. C. Bell, “A placebo-controlled randomized clinical trial of perioperative administration of gabapentin, rofecoxib and their combination for spontaneous and movement-evoked pain after abdominal hysterectomy,” Pain, vol. 113, no. 1-2, pp. 191–200, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Gilron, J. M. Bailey, D. Tu, R. R. Holden, D. F. Weaver, and R. L. Houlden, “Morphine, gabapentin, or their combination for neuropathic pain,” The New England Journal of Medicine, vol. 352, no. 13, pp. 1324–1334, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J. A. Haythornthwaite, “Clinical trials studying pharmacotherapy and psychological treatments alone and together,” Neurology, vol. 65, no. 12, pp. S20–S31, 2005. View at Google Scholar · View at Scopus
  9. N. Torrance, B. H. Smith, M. C. Watson, and M. I. Bennett, “Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin,” Family Practice, vol. 24, no. 5, pp. 481–485, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Morlion, “Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components,” Current Medical Research and Opinion, vol. 27, no. 1, pp. 11–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Mao, M. S. Gold, and M. M. Backonja, “Combination drug therapy for chronic pain: a call for more clinical studies,” Journal of Pain, vol. 12, no. 2, pp. 157–166, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. T. S. Carey, A. T. Evans, N. M. Hadler et al., “Acute severe low back pain: a population-based study of prevalence and care-seeking,” Spine, vol. 21, no. 3, pp. 339–344, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. R. A. Deyo, S. K. Mirza, and B. I. Martin, “Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002,” Spine, vol. 31, no. 23, pp. 2724–2727, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. L. G. Hart, R. A. Deyo, and D. C. Cherkin, “Physician office visits for low back pain: frequency, clinical evaluation, and treatment patterns from a U.S. National survey,” Spine, vol. 20, no. 1, pp. 11–19, 1995. View at Google Scholar · View at Scopus
  15. L. H. M. Pengel, R. D. Herbert, C. G. Maher, and K. M. Refshauge, “Acute low back pain: systematic review of its prognosis,” British Medical Journal, vol. 327, no. 7410, pp. 323–325, 2003. View at Google Scholar · View at Scopus
  16. J. W. Frymoyer and W. L. Cats-Baril, “An overview of the incidences and costs of low back pain,” Orthopedic Clinics of North America, vol. 22, no. 2, pp. 263–271, 1991. View at Google Scholar · View at Scopus
  17. M. Von Korff and K. Saunders, “The course of back pain in primary care,” Spine, vol. 21, no. 24, pp. 2833–2839, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. M. T. Vogt, C. K. Kwoh, D. K. Cope, T. A. Osial, M. Culyba, and T. W. Starz, “Analgesic usage for low back pain: impact on health care costs and service use,” Spine, vol. 30, no. 9, pp. 1075–1081, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Bernstein, T. S. Carey, and J. M. Garrett, “The use of muscle relaxant medications in acute low back pain,” Spine, vol. 29, no. 12, pp. 1346–1351, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Luo, R. Pietrobon, L. H. Curtis, and L. A. Hey, “Prescription of nonsteroidal anti-inflammatory drugs and muscle relaxants for back pain in the United States,” Spine, vol. 29, no. 23, pp. E531–E537, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Di Iorio, E. Henley, and A. Doughty, “A survey of primary care physician practice patterns and adherence to acute low back problem guidelines,” Archives of Family Medicine, vol. 9, no. 10, pp. 1015–1021, 2000. View at Google Scholar · View at Scopus
  22. R. Chou and L. H. Huffman, “Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline,” Annals of Internal Medicine, vol. 147, no. 7, pp. 505–514, 2007. View at Google Scholar · View at Scopus
  23. R. Baron and A. Binder, “Is sciatica neuropathic? The mixed pain concept,” Orthopade, vol. 33, no. 5, pp. 568–575, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Freynhagen, R. Baron, T. Tölle et al., “Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: a prospective observational pilot study (MIPORT),” Current Medical Research and Opinion, vol. 22, no. 3, pp. 529–537, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Freynhagen, R. Rolke, R. Baron et al., “Pseudoradicular and radicular low-back pain—a disease continuum rather than different entities? Answers from quantitative sensory testing,” Pain, vol. 135, no. 1-2, pp. 65–74, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. A. E. Hassan, H. A. Saleh, Y. M. Baroudy et al., “Prevalence of neuropathic pain among patients suffering from chronic low back pain in Saudi Arabia,” Saudi Medical Journal, vol. 25, no. 12, pp. 1986–1990, 2004. View at Google Scholar · View at Scopus
  27. A. M. Kaki, A. Z. El-Yaski, and E. Youseif, “Identifying neuropathic pain among patients with chronic low-back pain: use of the Leeds Assessment of Neuropathic Symptoms and Signs pain scale,” Regional Anesthesia and Pain Medicine, vol. 30, no. 5, pp. 422.e1–422.e9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. C. O. Schmidt, B. Schweikert, C. M. Wenig et al., “Modelling the prevalence and cost of back pain with neuropathic components in the general population,” European Journal of Pain, vol. 13, no. 10, pp. 1030–1035, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. N. B. Finnerup, M. Otto, H. J. McQuay, T. S. Jensen, and S. H. Sindrup, “Algorithm for neuropathic pain treatment: an evidence based proposal,” Pain, vol. 118, no. 3, pp. 289–305, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. M. H. Moskowitz, “Pharmacotherapy neuropathic low back pain,” Current Pain and Headache Reports, vol. 7, no. 3, pp. 178–187, 2003. View at Google Scholar · View at Scopus
  31. C. L. Romanò, D. Romanò, C. Bonora, and G. Mineo, “Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain,” Journal of Orthopaedics and Traumatology, vol. 10, no. 4, pp. 185–191, 2009. View at Publisher · View at Google Scholar
  32. A. Gatti, A. F. Sabato, A. Carucci, L. Bertini, M. Mammucari, and R. Occhioni, “Adequacy assessment of oxycodone/paracetamol (acetaminophen) in multimodal chronic pain: a prospective observational study,” Clinical Drug Investigation, vol. 29, supplement 1, pp. 31–40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Pota, M. Maisto, M. C. Pace et al., “191 Association of buprenorphine TDS and pregabalin in the treatment of low back pain,” European Journal of Pain, vol. 11, no. S1, p. S83, 2007. View at Publisher · View at Google Scholar
  34. S. Khoromi, L. Cui, L. Nackers, and M. B. Max, “Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain,” Pain, vol. 130, no. 1-2, pp. 66–75, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. P. M. Peloso, L. Fortin, A. Beaulieu, M. Kamin, and N. R. Rosenthal, “Analgesic efficacy and safety of tramadol/acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial,” Journal of Rheumatology, vol. 31, no. 12, pp. 2454–2463, 2004. View at Google Scholar · View at Scopus
  36. G. E. Ruoff, N. Rosenthal, D. Jordan, R. Karim, and M. Kamin, “Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study,” Clinical Therapeutics, vol. 25, no. 4, pp. 1123–1141, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Bennett, “The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs,” Pain, vol. 92, no. 1-2, pp. 147–157, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Pérez, R. Gálvez, J. Insausti et al., “Linguistic adaptation and Spanish validation of the LANSS (Leeds Assessment of Neuropathic Symptoms and Signs) scale for the diagnosis of neuropathic pain,” Medicina Clinica, vol. 127, no. 13, pp. 485–491, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. T. J. Schnitzer, W. L. Gray, R. Z. Paster, and M. Kamin, “Efficacy of tramadol in treatment of chronic low back pain,” Journal of Rheumatology, vol. 27, no. 3, pp. 772–778, 2000. View at Google Scholar · View at Scopus
  40. A. Gatti, A. F. Sabato, R. Occhioni, G. Colini Baldeschi, and C. Reale, “Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study,” European Neurology, vol. 61, no. 3, pp. 129–137, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Lesser, U. Sharma, L. LaMoreaux, and R. M. Poole, “Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial,” Neurology, vol. 63, no. 11, pp. 2104–2110, 2004. View at Google Scholar · View at Scopus
  42. R. W. Richter, R. Portenoy, U. Sharma, L. Lamoreaux, H. Bockbrader, and L. E. Knapp, “Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial,” Journal of Pain, vol. 6, no. 4, pp. 253–260, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Meunier, B. Lisander, and L. Good, “Effects of celecoxib on blood loss, pain, and recovery of function after total knee replacement: a randomized placebo-controlled trial,” Acta Orthopaedica, vol. 78, no. 5, pp. 661–667, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Singh, J. G. Fort, J. L. Goldstein et al., “Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I study,” American Journal of Medicine, vol. 119, no. 3, pp. 255–266, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Kuijpers, M. van Middelkoop, S. M. Rubinstein et al., “A systematic review on the effectiveness of pharmacological interventions for chronic non-specific low-back pain,” European Spine Journal, vol. 20, no. 1, pp. 40–50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. T. J. Schnitzer, A. Ferraro, E. Hunsche, and S. X. Kong, “A comprehensive review of clinical trials on the efficacy and safety of drugs for the treatment of low back pain,” Journal of Pain and Symptom Management, vol. 28, no. 1, pp. 72–95, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Chou, A. Qaseem, V. Snow et al., “Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society,” Annals of Internal Medicine, vol. 147, no. 7, pp. 478–491, 2007. View at Google Scholar · View at Scopus
  48. A. P. White, P. M. Arnold, D. C. Norvell, E. Ecker, and M. G. Fehlings, “Pharmacologic management of chronic low back pain: synthesis of the evidence,” Spine, vol. 36, supplement 21, pp. S131–S143, 2011. View at Publisher · View at Google Scholar